MétaCan
Menu
Back to cohort

Depressive Symptoms and Amyloid Pathology

2025· article· en· W4406693206 on OpenAlexafffund
Wietse Wiels, Julie Elisabeth Oomens, Sebastiaan Engelborghs, Chris Baeken, Christine A. F. Von Arnim, Merçé Boada, Mira Didic, Bruno Dubois, Tormod Fladby, Wiesje M. van der Flier, Giovanni B. Frisoni, Lutz Fröhlich, Kiran Dip Gill, Timo Grimmer, Helmut Hildebrandt, Jakub Hort, Yoshiaki Itoh, Takeshi Iwatsubo, Aleksandra Klimkowicz‐Mrowiec, Dong Young Lee, Alberto Lleó, Pablo Martínez‐Lage, Alexandre de Mendonça, Philipp T. Meyer, Elisabeth Kapaki, Piero Parchi, Matteo Pardini, Lucilla Parnetti, Julius Popp, Lorena Rami, Eric M. Reiman, Juha O. Rinne, Karen M. Rodrigue, Pascual Sánchez‐Juan, Isabel Santana, Marie Sarazin, Nikolaos Scarmeas, Ingmar Skoog, Peter J. Snyder, Reisa A. Sperling, Sylvia Villeneuve, Anders Wallin, Jens Wiltfang, Henrik Zetterberg, Rik Ossenkoppele, Frans R.J. Verhey, Stephanie J. B. Vos, Pieter Jelle Visser, Willemijn J. Jansen, Daniel Alcolea, Daniele Altomare, Simone Baiardi, Inês Baldeiras, Randall J. Bateman, Kaj Blennow, Michel Bottlaender, Anouk den Braber, Mark A. van Buchem, Min Soo Byun, Jiří Cerman, Kewei Chen, Elena Chipi, Gregory S. Day, Alexander Drzezga, Marie Eckerström, Laura L. Ekblad, Stéphane Epelbaum, Stefan Förster, Juan Fortea, Yvonne Freund‐Levi, Lars Frings, Éric Guedj, Lucrezia Hausner, Sabine Hellwig, Edward D. Huey, J. Jiménez‐Bonilla, Keith A. Johnson, Arantxa Juaristi, Ramesh Kandimalla, George P. Paraskevas, Silke Kern, Bjørn‐Eivind Kirsebom, Johannes Kornhuber, Julien Lagarde, Susan Landau, Nienke Legdeur, Jorge J. Llibre Guerra, Nancy N. Maserejian, Marta Marquié, Shinobu Minatani, Silvia Morbelli, Barbara Mroczko, Eva Ntanasi, Catarina R. Oliveira, Pauline Olivieri, Adelina Orellana, Richard J. Perrin, Oliver Peters, Sudesh Prabhakar, Inez H. Ramakers, Eloy Rodríguez‐Rodríguez, Agustín Ruiz, E. Rüther, Per Selnes, Dina Silva, Hilkka Soininen, Luiza Spiru, Akitoshi Takeda, Marc Teichmann, Betty M. Tijms, Charlotte E. Teunissen, Jonathan Vogelgsangs, Jonathan Vöglein, Gunhild Waldemar, Åsa K. Wallin, Mary Yannakoulia, Dahyun Yi, Anna Zettergren

Bibliographic record

VenueJAMA Psychiatry · 2025
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsMcGill UniversityDouglas Mental Health University InstituteMontreal Neurological Institute and Hospital
FundersNational Bioscience Database CenterNational Institute of Neurological Disorders and StrokeNational Institute on AgingMedizinische Fakultät der Albert-Ludwigs-Universität FreiburgNational Institute of Mental HealthInstitut de Recherches ServierSahlgrenska AkademinInstituto de Salud Carlos IIICollege of Medicine, Seoul National UniversityTau ConsortiumGenentechNational Institutes of HealthGIESKES-STRIJBIS FONDSEuropean Brain CouncilOlav Thon StiftelsenInstitut d’Investigacions Biomèdiques August Pi i Sunyer, Universitat de BarcelonaUK Dementia Research InstituteCentro de Investigación Biomédica en Red sobre Enfermedades NeurodegenerativasEuropean Federation of Pharmaceutical Industries and AssociationsInstitut National de la Santé et de la Recherche MédicaleH. Lundbeck A/SUniwersytet Jagielloński Collegium MedicumUniversity College LondonOryzon GenomicsFondation pour la Recherche sur AlzheimerRadboud Universitair Medisch CentrumEli Lilly and CompanyUniversidade de LisboaEusko JaurlaritzaGöteborgs UniversitetUniversidade de CoimbraWeill Cornell Medical CollegeUniversity of PennsylvaniaFujirebio EuropeUniversity of TokyoUniversità degli Studi di GenovaInternational Atomic Energy AgencySchool of Medicine and Public Health, University of Wisconsin-MadisonNovo NordiskVetenskapsrådetBanco Bilbao Vizcaya ArgentariaKyowa Hakko KirinSahlgrenska UniversitetssjukhusetHjärnfondenSanofiLeids Universitair Medisch CentrumEisaiMcGill UniversityUniverzita Karlova v PrazeGeneralitat de CatalunyaWydział Lekarski, Uniwersytet Jagielloński Collegium MedicumJulius ClinicalStichting DioraphteEuropean Regional Development FundAlzheimer's Research TrustSeoul National UniversityServierGrifolsUniversity of Texas at DallasZonMwBayer VitalAlzheimer NederlandJapan Science and Technology AgencyEberhard Karls Universität TübingenSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungTechnische Universität MünchenNederlandse Organisatie voor Wetenschappelijk OnderzoekDeutsche ForschungsgemeinschaftNational Science FoundationUniversité de LausanneHORIZON EUROPE Framework ProgrammeAlbert-Ludwigs-Universität FreiburgIndian Council of Medical ResearchVlaamse regeringNational Research FoundationFoundation for Barnes-Jewish HospitalNational Institute for Health and Care ResearchUniversitätsmedizin GöttingenUnion Chimique BelgeGood Ventures FoundationCentene CorporationRoche NederlandNational and Kapodistrian University of AthensHealth~HollandAlzheimer's AssociationHersenstichtingBrigham and Women's HospitalAvid RadiopharmaceuticalsTarget ALSPfizerEU Joint Programme – Neurodegenerative Disease ResearchSiemens HealthineersFundació la Marató de TV3Commissariat à l'Énergie Atomique et aux Énergies AlternativesDemensförbundetCure Alzheimer's FundKarolinska InstitutetTurun YliopistoYale UniversityAlzheimer's Drug Discovery FoundationUniversity of Wisconsin-MadisonEuropean CommissionProthenaFaculty of Medicine, McGill UniversityCelgeneBrightFocus FoundationHarvard UniversityF. Hoffmann-La RocheBiogenIonis PharmaceuticalsCarl von Ossietzky Universität OldenburgUniversità di BolognaAstraZenecaBristol-Myers SquibbAssociation for Frontotemporal DegenerationDanoneFamiljen Erling-Perssons StiftelseCilagAmgenStiftelsen för Gamla TjänarinnorLunds UniversitetFundación BBVA
KeywordsBiomarkerMedicineDementiaDepression (economics)Geriatric Depression ScaleInternal medicineClinical Dementia RatingPopulationApolipoprotein EAmyloid (mycology)PsychiatryPathologyOncologyCognitionDepressive symptomsDisease

Abstract

fetched live from OpenAlex

Importance: Depressive symptoms are associated with cognitive decline in older individuals. Uncertainty about underlying mechanisms hampers diagnostic and therapeutic efforts. This large-scale study aimed to elucidate the association between depressive symptoms and amyloid pathology. Objective: To examine the association between depressive symptoms and amyloid pathology and its dependency on age, sex, education, and APOE genotype in older individuals without dementia. Design, Setting, and Participants: Cross-sectional analyses were performed using data from the Amyloid Biomarker Study data pooling initiative. Data from 49 research, population-based, and memory clinic studies were pooled and harmonized. The Amyloid Biomarker Study has been collecting data since 2012 and data collection is ongoing. At the time of analysis, 95 centers were included in the Amyloid Biomarker Study. The study included 9746 individuals with normal cognition (NC) and 3023 participants with mild cognitive impairment (MCI) aged between 34 and 100 years for whom data on amyloid biomarkers, presence of depressive symptoms, and age were available. Data were analyzed from December 2022 to February 2024. Main Outcomes and Measures: Amyloid-β1-42 levels in cerebrospinal fluid or amyloid positron emission tomography scans were used to determine presence or absence of amyloid pathology. Presence of depressive symptoms was determined on the basis of validated depression rating scale scores, evidence of a current clinical diagnosis of depression, or self-reported depressive symptoms. Results: In individuals with NC (mean [SD] age, 68.6 [8.9] years; 5664 [58.2%] female; 3002 [34.0%] APOE ε4 carriers; 937 [9.6%] had depressive symptoms; 2648 [27.2%] had amyloid pathology), the presence of depressive symptoms was not associated with amyloid pathology (odds ratio [OR], 1.13; 95% CI, 0.90-1.40; P = .29). In individuals with MCI (mean [SD] age, 70.2 [8.7] years; 1481 [49.0%] female; 1046 [44.8%] APOE ε4 carriers; 824 [27.3%] had depressive symptoms; 1668 [55.8%] had amyloid pathology), the presence of depressive symptoms was associated with a lower likelihood of amyloid pathology (OR, 0.73; 95% CI 0.61-0.89; P = .001). When considering subgroup effects, in individuals with NC, the presence of depressive symptoms was associated with a higher frequency of amyloid pathology in APOE ε4 noncarriers (mean difference, 5.0%; 95% CI 1.0-9.0; P = .02) but not in APOE ε4 carriers. This was not the case in individuals with MCI. Conclusions and Relevance: Depressive symptoms were not consistently associated with a higher frequency of amyloid pathology in participants with NC and were associated with a lower likelihood of amyloid pathology in participants with MCI. These findings were not influenced by age, sex, or education level. Mechanisms other than amyloid accumulation may commonly underlie depressive symptoms in late life.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.077
Threshold uncertainty score0.322

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.005
GPT teacher head0.298
Teacher spread0.292 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations20
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJAMA PsychiatrySame topicDementia and Cognitive Impairment ResearchFrench-language works237,207